United States Non Invasive Prenatal Testing (NIPT) Market Analysis Report 2023: Growing Focus on Reimbursement for Non-invasive Prenatal Testing - Forecasts to 2031


Dublin, July 04, 2023 (GLOBE NEWSWIRE) -- The "United States Non Invasive Prenatal Testing (NIPT) Market Size, Market Share, Insights, Growth, Trends, Opportunities, Key Players, Competitive Analysis and Forecast 2023 to 2031" report has been added to ResearchAndMarkets.com's offering.

The non-invasive prenatal testing (NIPT) market in the United States is expected to reach USD 2,653 million by 2031. The market is expected to register a CAGR of more than 13% in the forecast period.

The report on the non-invasive prenatal testing (NIPT) market in the United States is a comprehensive study and presentation of drivers, restraints, opportunities, demand, market size, insights, forecasts, and trends in the non-invasive prenatal testing (NIPT) market in the United States during 2019 - 2031. Furthermore, the report includes historic market data from 2019 to 2022 and forecast until 2031.

The growth of the market depends on several factors, including the increase in the incidence of chromosomal aneuploidies in fetuses, the progress of advanced non-invasive prenatal testing products, the increasing acceptance of non-invasive prenatal testing, the growing focus on reimbursement for non-invasive prenatal testing, the rising preference for non-invasive techniques over invasive methods, and the ACOG guidelines recommending NIPT for all pregnancies regardless of risk.

The Most Important Questions are Answered in this Current 2023 Report:

  • What is the current scenario of the non-invasive prenatal testing market in the United States?
  • What is the total market size for non-invasive prenatal testing in the United States and what are the projections (through 2031) for this market?
  • How large is the market for noninvasive prenatal testing in the United States?
  • Which is the top non-invasive prenatal test available in the united states?
  • How has the potential market performed so far and how will it perform in the coming years?
  • How many NIPT tests are being performed in the united states during 2019-2031?
  • What is the market size of the average risk NIPT tests in the united states?
  • What is the market size of the high-risk NIPT tests in the united states?
  • What are the key marketed NIPT tests available in the united states?
  • What are the major drivers of the united states non-invasive prenatal testing market?
  • What are the major inhibitors of the united states non-invasive prenatal testing market?
  • What is the reimbursement pattern in the united states non-invasive prenatal testing market?
  • What is the regulatory framework in the united states non-invasive prenatal testing market?
  • What are the major deals and agreement happenings in the united states non-invasive prenatal testing market?
  • What companies offer NIPT tests in the united states?
  • Who are the top market players? What are their happenings, current developments, and scenarios?
  • How is the market predicted to develop in the future?
  • What is the degree of competition in the industry?

Key Players in the United States Non-Invasive Prenatal Testing Market are Listed Below:

  • Illumina, Inc.
  • Natera, Inc.
  • Quest Diagnostics
  • Myriad Genetics, Inc.
  • Centogene
  • GenPath
  • PerkinElmer
  • Yourgene Health
  • Invitae Corporation
  • Agilent Technologies
  • Ariosa Diagnostics (Roche)
  • Laboratory Corporation of America Holdings (Labcorp)

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. United States Actual Non-Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2019 - 2031)
4.1 Average Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast
4.2 High-Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast

5. United States Potential Non-Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2019 - 2031)
5.1 Average Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast
5.2 High-Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast

6. United States Actual Non-Invasive Prenatal Testing Market Size and Forecast (2019 - 2031)
6.1 Average Risk Actual NIPT Test Market Size and Forecast
6.2 High-Risk Actual NIPT Test Market Size and Forecast

7. United States Potential Non-Invasive Prenatal Testing Market Size and Forecast (2019 - 2031)
7.1 Average Risk Potential NIPT Test Market Size and Forecast
7.2 High-Risk Potential NIPT Test Market Size and Forecast

8. United States Non-Invasive Prenatal Testing Market Growth Drivers and Challenges
8.1 Key Market Growth Drivers
8.2 Key Market Challenges

9. Non-Invasive Prenatal Testing Comparative Analysis

10. Reimbursement Environment of the United States Non-Invasive Prenatal Testing

11. Regulation Framework of the United States Non-Invasive Prenatal Testing

12. Major Deals and Agreements in the Non-Invasive Prenatal Testing Market
12.1 Collaboration Deals
12.2 Venture Capital Investment
12.3 Mergers and Acquisitions
12.4 Exclusive Agreement
12.5 Licensing Agreement
12.6 Distribution Agreement
12.7 Partnership Deals

13. Key Companies Analysis
13.1 Business Overview
13.2 Product Outlook
13.3 Key Developments

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/43t5xr

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
US Non-Invasive Prenatal Testing (NIPT) Market

Coordonnées